Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 12Antibiotic Use and ResistanceAntibiotic Resistance in BacteriaSalmonella and Campylobacter epidemiology

The DOI matches its Crossref record.

The UK Fleming Fund: Developing AMR surveillance capacity in low- and middle-income countries

Open access
Gordon, N., Aggarwal, V., Amos, B., Buhler, C., Huszar, A., McKenzie, J., Mitchell, J., Moyen, N., Mubangizi, P., Leslie, T.·2020·International Journal of Infectious Diseases

Abstract

Background: The Fleming Fund is a UK Overseas Development Aid programme aiming to improve Antimicrobial Resistance (AMR) surveillance in low-and middle-income countries in Africa and Asia. The Fund has placed Country Grants in over 20 countries, to support implementation of the surveillance component of country AMR National Action Plans. Grants provide funding and technical assistance to develop AMR governance systems, and to improve capacity for bacteriology diagnostics, AMR reporting and data analysis. In rolling out the programme, we have accumulated a substantial dataset on AMR surveillance capacity across a broad range of settings. Methods and materials: As part of the grant placement process, we undertook a series of visits to each country to assess their AMR surveillance system and identify gaps which could be filled by the programme. Visits followed a standardised approach, which included meetings with AMR coordination committees, Ministries of Health, Agriculture, Fisheries and the Environment, FAO and WHO, and other relevant AMR stakeholders. The visits reviewed the sectors involved in AMR surveillance, the governance structure, national policies and strategies, key actors and activities, and barriers to implementation of National Action Plans. Results: Although countries varied in the maturity of their AMR surveillance systems, none had a fully functioning, integrated system. Common factors preventing implementation of surveillance were: a lack of coherent governance systems, lack of clarity regarding roles and responsibilities of different ministries, budget constraints, lack of technical expertise in surveillance design and data analysis, and poor IT and reporting systems. Conversely, we found differences in the rapidity of implementation, often related to the complexity of clinical and public health service governance. Conclusion: We have developed a comprehensive approach to assessing country capacity for AMR surveillance. Whilst the majority of countries have developed National Action Plans for AMR, implementation is universally hampered by lack of funding, poor inter-ministerial coordination, and limited technical expertise. Systematic identification of these issues will enable the Fleming Fund to adapt its programme to a wide range of situations and levels of capacity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijid.2020.09.137

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Still being checked.

Cited by

Metadata

Authors
Gordon, N., Aggarwal, V., Amos, B., Buhler, C., Huszar, A., McKenzie, J., Mitchell, J., Moyen, N., Mubangizi, P., & Leslie, T.
Affiliations
  • Mott MacDonald (United Kingdom) (GB)
  • Massey University (NZ)
Corresponding author
Gordon, N.
Venue
International Journal of Infectious Diseases
Publisher
Elsevier BV
Published
2020-12
Volume
101
Pages
40
ISSN
1201-9712 (ISSN-L)
OpenAlex
W3125739576
Cited by
12
References
0
Citations by year
2026: 2 · 2025: 2 · 2024: 6 · 2023: 1 · 2022: 1
FWCI
0.30
Type
journal article
Language
en
Open access
Locations
  • International Journal of Infectious Diseases (publishedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
Keywords
antimicrobial resistance surveillance, low- and middle-income countries, AMR governance, inter-ministerial coordination, technical assistance, development aid, implementation barriers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review